Stoichiometry of tyrosine hydroxylase phosphorylation in the nigrostriatal and mesolimbic systems in vivo: Effects of acute haloperidol and related compounds

Journal of Neurochemistry

Volumn 75, Issue 1, 2000, Pages 225-232

  Salvatore, Michael F ^a,d   Garcia Espana, Antonio ^b   Goldstein, Menek ^b   Deutch, Ariel Y ^c   Haycock, John W ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Catecholamine; Clozapine; Labile epitopes; Raclopride; SCH23390

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLOZAPINE; EPITOPE; HALOPERIDOL; PHOSPHORUS 32; RACLOPRIDE; SERINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ELECTROSTIMULATION; IN VIVO STUDY; LIMBIC SYSTEM; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; STOICHIOMETRY; VENTRAL TEGMENTUM;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BRAIN; CLOZAPINE; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; HALOPERIDOL; HYPOTHALAMUS; MALE; NUCLEUS ACCUMBENS; PHOSPHORYLATION; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

ANIMALIA;

EID: 0034085534     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0750225.x     Document Type: Article

References (47)

1. Albert K. A., Helmer-Matyjek E., Nairn A. C., Muller T. H., Haycock J. W., Greene L. A., Goldstein M., and Greengard P. (1984) Calcium/phospholipid-dependent protein kinase (protein kinase C) phosphorylates and activates tyrosine hydroxylase. Proc. Natl. Acad. Sci. USA 81, 7713-7717.
2. Argiolas A., Fadda F., Melis M. R., and Gessa G. L. (1979) Haloperidol increases DOPAC in the substantia nigra but not in the ventral tegmental area. Life Sci. 24, 2279-2284.
3. Argiolas A., Fadda F., Melis M. R., and Gessa G. L. (1980) Differential effect of haloperidol on DOPAC levels in the substantia nigra and ventral tegmental area. Pharmacol. Res. Commun. 12, 683-688.
4. Argiolas A., Melis M. R., Fadda F., Serra G., and Gessa G. L. (1982) Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra. J. Neurochem. 38, 75-79.
5. Bunney B. S., Walters J. R., Roth R. H., and Aghajanian G. K. (1973) Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther. 185, 560-571.
6. Bunney B. S., Skirboll L. R., and Grace A. A. (1980) Acute and chronic haloperidol treatment: effects on nigrostriatal dopaminergic system activity. Adv. Biochem. Psychopharmacol. 24, 267-273.
7. Cragg S. J. and Greenfield S. A. (1997) Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J. Neurosci. 17, 5738-5746.
8. Daubner S. C., Lauriano C., Haycock J. W., and Fitzpatrick P. F. (1992) Site-directed mutagenesis of serine 40 of rat tyrosine hydroxylase: effects of dopamine and cAMP-dependent phosphorylation on enzyme activity. J. Biol. Chem. 267, 12639-12646.
9. Funakoshi H., Okuno S., and Fujisawa H. (1991) Different effects on activity caused by phosphorylation of tyrosine hydroxylase at serine 40 by three multifunctional protein kinases. J. Biol. Chem. 266, 15614-15620.
10. Gale K., Costa E., Toffano G., Hong J.-S., and Guidotti A. (1978) Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 206, 29-37.
11. Gudelsky G. A. and Meltzer H. Y. (1989) Activation of tuberoinfundibular dopamine neurons following the acute administration of atypical antipsychotics. Neuropsychopharmacology 2, 45-51.
12. Haavik J., Martinez A., and Flatmark T. (1990) pH-dependent release of catecholamines from tyrosine hydroxylase and the effect of phosphorylation at Ser-40. FEBS Lett. 262, 363-365.
13. Harada K., Wu J., Haycock J. W., and Goldstein M. (1996) Regulation of L-DOPA biosynthesis by site-specific phosphorylation of tyrosine hydroxylase in AtT-20 cells expressing wild-type and serine 40-substituted enzyme. J. Neurochem. 67, 629-635.
14. Haycock J. W. (1989) Quantitation of tyrosine hydroxylase protein levels: spot immunolabeling with an affinity purified antibody. Anal. Biochem. 181, 259-266.
15. Haycock J. W. (1990) Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, 40. J. Biol. Chem. 265, 11682-11691.
16. Haycock J. W. (1996) Short- and long-term regulation of tyrosine hydroxylase in chromaffin cells by VIP and PACAP. Ann. NY Acad. Sci. 805, 219-231.
17. Haycock J. W. and Haycock D. A. (1991) Tyrosine hydroxylase in rat brain dopaminergic nerve terminals: multiple-site phosphorylation in vivo and in synaptosomes. J. Biol. Chem. 266, 5650-5657.
18. Haycock J. W., Ahn N. G., Cobb M. H., and Krebs E. G. (1992) ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc. Natl. Acad. Sci. USA 89, 2365-2369.
19. Haycock J. W., Lew J. Y., Garcia-Espana A., Lee K. Y., Harada K., Meller E., and Goldstein M. (1998) Role of serine-19 phosphorylation in regulating tyrosine hydroxylase studied with site- and phosphospecific antibodies and site-directed mutagenesis. J. Neurochem. 71, 1670-1675.
20. Hjorth S. and Carlsson A. (1988) In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390. J. Neural Transm. 72, 83-97.
21. Hoffman A. F. and Gerhardt G. A. (1999) Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: an in vivo electrochemical study. J. Pharmacol. Exp. Ther. 289, 455-463.
22. Iorio L. C., Barnett A., Leitz F. H., Houser V. P., and Korduba C. A. (1983) SCH23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmacol. Exp. Ther. 226, 462-468.
23. Lew J. Y., Garcia-Espana A., Lee K. Y., Carr K. D., Goldstein M., Haycock J. W., and Meller E. (1998) Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity. Mol. Pharmacol. 55, 202-209.
24. Magnusson O., Mohringe B., and Fowler C. J. (1987) Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation. J. Neural Transm. 69, 163-177.
25. Mitchell J. P., Hardie D. G., and Vulliet P. R. (1990) Site-specific phosphorylation of tyrosine hydroxylase after KCl depolarization and nerve growth factor treatment of PC12 cells. J. Biol. Chem. 265, 22358-22364.
26. Murrin C. and Roth R. H. (1976) Dopaminergic neurons: effects of electrical stimulation on dopamine biosynthesis. Mol. Pharmacol. 12, 463-475.
27. Murrin C., Morgenroth V. H., and Roth R. H. (1976) Dopaminergic neurons: effects of electrical stimulation on tyrosine hydroxylase. Mol. Pharmacol. 12, 1070-1081.
28. Nissbrandt H., Sundström E., Jonsson G., Hjorth S., and Carlsson A. (1989) Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacta, pars reticulata, and striatum. J. Neurochem. 52, 1170-1182.
29. Ordway G. A., Smith K. S., and Haycock J. W. (1994) Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. J. Neurochem. 62, 680-685.
30. Ramsey A. J. and Fitzpatrick P. F. (1998) Effects of phosphorylation of serine 40 of tyrosine hydroxylase on binding of catecholamines: evidence for a novel regulatory mechanism. Biochemistry 37, 8980-8986.
31. Roskoski R. Jr., Vulliet P. R., and Glass D. B. (1987) Phosphorylation of tyrosine hydroxylase by cyclic GMP-dependent protein kinase. J. Neurochem. 48, 840-845.
32. Salah R. S., Kuhn D. M., and Galloway M. P. (1989) Dopamine autoreceptors modulate the phosphorylation of tyrosine hydroxylase in rat striatal slices. J. Neurochem. 52, 1517-1522.
33. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., and Klenk D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76-85.
34. Stoof J. C. and Kebabian J. W. (1981) Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294, 366-368.
35. Strait K. A. and Kuczenski R. (1986) Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase. Mol. Pharmacol. 29, 561-569.
36. Sutherland C., Alterio J., Campbell D. G., LeBourdelles B., Mallet J., Haavik J., and Cohen P. (1993) Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2. Eur. J. Biochem. 217, 715-722.
37. Thomas G., Haavik J., and Cohen P. (1997) Participation of a stress-activated protein kinase cascade in the activation of tyrosine hydroxylase in chromaffin cells. Eur. J. Biochem. 247, 1180-1189.
38. Vulliet P. R., Langan T. A., and Weiner N. (1980) Tyrosine hydroxylase: a substrate for cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 77, 92-96.
39. Vulliet P. R., Woodgett J. R., and Cohen P. (1984) Phosphorylation of tyrosine hydroxylase by calmodulin-dependent multiprotein kinase. J. Biol. Chem. 259, 13680-13683.
40. 2+ and phospholipid-dependent protein kinase, calmodulin-dependent multiprotein kinase and cyclic AMP-dependent protein kinase. FEBS Lett. 182, 335-339.
41. Waymire J. C., Johnston J. P., Hummer-Lickteig K., Lloyd A., Vigny A., and Craviso G. L. (1988) Phosphorylation of bovine adrenal chromaffin cell tyrosine hydroxylase: temporal correlation of acetylcholine's effect on site phosphorylation, enzyme activation, and catecholamine synthesis. J. Biol. Chem. 263, 12439-12447.
42. Waymire J. C., Craviso G. L., Lichteig K., Johnston I. P., Baldwin C., and Zigmond R. E. (1991) Vasoactive intestinal peptide stimulates catecholamine biosynthesis in isolated adrenal chromaffin cells: evidence for a cyclic AMP-dependent phosphorylation and activation of tyrosine hydroxylase. J. Neurochem. 57, 1313-1324.
43. Westerink B. H. C. and Korf J. (1976) Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain. Eur. J. Pharmacol. 40, 131-136.
44. Zivkovic B. and Guidotti A. (1974) Changes of kinetic constant of striatal tyrosine hydroxylase elicited by neuroleptics that impair the function of dopamine receptors. Brain Res. 79, 505-509.
45. Zivkovic B., Guidotti A., and Costa E. (1974) Effects of neuroleptics on striatal tyrosine hydroxylase: changes in affinity for the pteridine cofactor. Mol. Pharmacol. 10, 727-735.
46. Zivkovic B., Guidotti A., and Costa E. (1975a) The regulation of striatal tyrosine hydroxylase: effects of gamma hydroxybutyric acid and haloperidol. Naunyn Schmeidebergs Arch. Pharmacol. 291, 193-200.
47. Zivkovic B., Guidotti A., Revuelta A., and Costa E. (1975b) Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 194, 37-46.